Last reviewed · How we verify

NCT07052487

Effectiveness of Post Isometric Relaxation Technique Versus Simple Stretching Exercises for Pain and Physical Activity in Young Females With Primary Dysmenorrhea in Peshawar

Completed NA Last updated 5 January 2026
What this trial tests

NA trial testing Post-Isometric Relaxation (PIR) in Dysmenorrhea in 44 participants. Completed in 30 October 2025.

Timeline
1 July 2025
Primary endpoint
10 September 2025
30 October 2025

Quick facts

Lead sponsorKhyber Medical University Peshawar
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment44
Start date1 July 2025
Primary completion10 September 2025
Estimated completion30 October 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Khyber Medical University Peshawar

Who can join

Adults 18 to 30, female only, with Dysmenorrhea or Menstrual Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial will compare the effectiveness of Post-Isometric Relaxation (PIR) versus Simple Stretching Exercises (SSE), each combined with standard physiotherapy modalities, for reducing menstrual pain and improving physical activity in young unmarried women with primary dysmenorrhea. Forty-four participants will be randomly assigned (1:1) to receive either PIR or SSE three times per week for eight weeks (24 total sessions). The study will identify which non-pharmacological intervention provides superior benefits for pain relief and daily function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Post-Isometric Relaxation (PIR)

Trials testing the same drug.

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

Other Khyber Medical University Peshawar trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07052487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing